What is the appropriate hydroxyzine dose for a patient receiving chronic dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydroxyzine Dosing in Dialysis Patients

For patients on chronic hemodialysis, hydroxyzine should be dosed at 25 mg once daily, with the dose reduced by half from the standard adult dose due to renal excretion and risk of accumulation. 1

Dose Adjustment Rationale

Hydroxyzine requires dose reduction in dialysis patients because:

  • The extent of renal excretion has not been fully determined, but elderly patients and those with decreased renal function require cautious dosing 1
  • The FDA label specifically states that "care should be taken in dose selections" for patients with renal impairment 1
  • Hemodialysis contributes minimally to hydroxyzine clearance, meaning the drug is not effectively removed during dialysis sessions 1

Specific Dosing Recommendations

Standard adult dose: 25-50 mg for anxiety/pruritus

Dialysis patient dose:

  • Start with 25 mg once daily (half the standard dose) 2
  • Maximum dose should not exceed 25 mg daily in severe renal impairment (creatinine clearance <10 mL/min) 2
  • Timing relative to dialysis is not critical since hemodialysis does not significantly remove the drug 1

Clinical Evidence in Dialysis Patients

The research evidence supports hydroxyzine use in dialysis patients specifically for uremic pruritus:

  • Hydroxyzine 25 mg/day was effective in treating pruritus in hemodialysis patients in a randomized crossover trial, significantly reducing pruritus severity over 6 weeks 3
  • This lower dose (25 mg daily) was both effective and well-tolerated in the dialysis population 4

Critical Safety Considerations

Monitor closely for:

  • Excessive sedation - the most common manifestation of accumulation 1
  • QT prolongation - dialysis patients often have electrolyte imbalances and cardiac disease, increasing risk 1
  • Confusion and over-sedation - particularly important as many dialysis patients are elderly 1

Avoid or use extreme caution if:

  • Severe hepatic impairment present 2
  • Concurrent use of other QT-prolonging medications 1
  • Pre-existing cardiac arrhythmias or recent myocardial infarction 1

Common Pitfall

Do not use standard adult doses (50 mg) in dialysis patients. The drug accumulates because it is not dialyzed out, and renal clearance is impaired. Starting at 25 mg daily provides therapeutic benefit while minimizing sedation and other adverse effects 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.